Bellevue Life Sciences Acquisition Corp.

BLAC | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.01

-$3.72 (-55.27%)

Feb 14, 2025, 04:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $6.98M

Enterprise Value $6.06M

Beta 0.53

Average Volume N/A

Shares Outstanding (Diluted) N/A

Shares Change YoY N/A

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -73.9%

1Y CAGR (ann.) -71.3%

5Y CAGR (ann.) N/A

All-Time CAGR -46.8%

Valuation

PE Ratio 0.84

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.01

PS Ratio 3.86

Forward PS N/A

PB Ratio 0.06

P/FCF Ratio -2.43

P/Adj. FCF Ratio -2.43

P/OCF Ratio -4.70

EV/Sales 3.35

EV/EBIT 1.17

EV/EBITDA -0.64

EV/FCF -2.11

Earnings Yield 119.6%

FCF Yield -41.2%

Adj. FCF Yield -41.2%

Financial Health

Net Cash $921.42K

Total Debt $578.19K

Cash & Short-Term Investments $1.5M

Total Assets $166.62M

Current Ratio 0.18

Quick Ratio 0.14

Debt / Equity Ratio 0.00

Debt / EBITDA -0.06

Debt / FCF -0.20

OCF / Debt -4.97

Interest Coverage 173.66

Altman Z-Score -0.22

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 35.3%

Operating Profit Margin -933.8%

EBITDA Margin -520.3%

Net Profit Margin 671.6%

FCF Margin -159.0%

Adj. FCF Margin -159.0%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 7.3%

Return on Equity 12.6%

Return on Invested Capital -10.6%

Return on Capital Employed -11.2%

Return on Tangible Assets 368.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 73.2%

Revenue CAGR 5Y 74.4%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 355.5%

EPS CAGR 5Y 237.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -26.7%

FCF CAGR 5Y -36.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Sep 29, 2023

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $47.51

Graham Upside 1478.4%

Lynch Fair Value $90

Lynch Upside 2890.0%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-2.88M

Free Cash Flow $-2.88M

Adj. Free Cash Flow $-2.88M

FCF Per Share -$0.64

OCF Per Share -$0.64

OCF/S Ratio -159.0%

Income Statement

Revenue $1.81M

Gross Profit $638.32K

Operating Income $-16.89M

EBITDA $-9.41M

Net Income $12.15M

EPS (Diluted) $3.60

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A